Wednesday, April 1, 2015
YOLO COUNTY NEWS
99 CENTS

UCD: Drug holds promise for reducing heart disease

By
From page A9 | August 02, 2013 |

UC Davis researchers have shown more promise in a new approach to heart disease, developing a way to block a key protein rather than targeting high blood pressure or cholesterol.

The experimental agent inhibits C-reactive protein, a biomarker of heart attacks, strokes and chest pain. Results were published online last week in the “International Journal of Cardiology.”

The researchers’ new tack is based on recent studies showing that the body’s inflammatory response is key to development of fatty deposits in blood vessels to heart attacks and strokes.

Patients whose C-reactive protein levels are high are at risk for suffering a heart attack, stroke or sudden death from cardiovascular disease — even if their blood cholesterol and blood pressure are normal, said Ishwarlal Jialal, senior author of the article and professor of pathology and laboratory medicine, in a news release.

“There is an urgent need to develop inhibitors that specifically block the biological effects of C-reactive protein,” Jialal said.

Some 15 to 20 percent of heart attacks and strokes occur in patients without well-established risk factors like high blood pressure and blood cholesterol, obesity, lack of regular exercise and cigarette smoking, according to UCD.

The immune system produces CRP to clear dead and disintegrating cells. It is usually found in the blood in trace amounts.

Jialal’s lab successfully used a synthesized peptide, a small protein molecule, to reduce inflammation caused by human CRP injected into rats. Rats’ bodies don’t normally produce the protein, but research elsewhere has shown injecting rats with human CRP increases tissue damage from heart attacks or strokes.

The UCD team has previously reduced CRP levels in cultures of human cells.

The experimental agent is the third known CRP inhibitor under development, according to UCD. Before human trials can take place, the lab plans to conduct five years worth of studies to evaluate the inhibitor’s long-term effects.

— Reach Cory Golden at [email protected] or 530-747-8046. Follow him on Twitter at @cory_golden

Comments

comments

Cory Golden

Cory Golden

The Enterprise's higher-education and congressional reporter. http://about.me/cory_golden
.

News

Food Bank springs for year-round assistance

By Anne Ternus-Bellamy | From Page: A1 | Gallery

 
 
Next-generation GMOs: Pink pineapples and purple tomatoes

By The Associated Press | From Page: A2 | Gallery

 
Dismal snowpack gets one more measure

By The Associated Press | From Page: A2

 
Funding sought for slain vet student’s pets

By Lauren Keene | From Page: A2

Museum celebrates Easter with candy-filled eggs

By Enterprise staff | From Page: A3

 
Easter egg hunt set Sunday at Atria

By Enterprise staff | From Page: A3

AquaMonsters open summer registration

By Special to The Enterprise | From Page: A3

 
Woodland Library’s community room reopens

By Enterprise staff | From Page: A3

 
Odd Fellows will host a big birthday bash

By Special to The Enterprise | From Page: A6

Tamblyn presents a comedy concert

By Special to The Enterprise | From Page: A6 | Gallery

 
Cancer fighters will gather Saturday for Relay For Life kickoff

By Special to The Enterprise | From Page: A6

Poet laureate emerita celebrates at book-release party

By Special to The Enterprise | From Page: A6

 
UCD gets grant to look at open access to published research

By Special to The Enterprise | From Page: A6

AARP’s free tax-prep services continue

By Special to The Enterprise | From Page: A7

 
Round up at the registers for Davis schools

By Enterprise staff | From Page: A7

‘Sip and Shop’ kicks off Child Abuse Prevention Month

By Special to The Enterprise | From Page: A7

 
Pain management lecture slated April 8

By Special to The Enterprise | From Page: A8

Seniors invited to join new social group

By Anne Ternus-Bellamy | From Page: A8

 
Pence Gallery: See artists at work during Garden Tour

By Natalie Nelson | From Page: A10 | Gallery

.

Forum

Is Davis on the cusp of an evolutionary change?

By Rich Rifkin | From Page: B4

 
Will containers block cyclists’ path?

By Letters to the Editor | From Page: B4

We have no room for another cart

By Letters to the Editor | From Page: B4

 
This is no way to run a city

By Letters to the Editor | From Page: B4

Get informed on organics program

By Letters to the Editor | From Page: B4

 
Bicycle bells are my birthday wish

By Letters to the Editor | From Page: B4

Tom Meyer cartoon

By Debbie Davis | From Page: B4

 
Shootings showed need for MRAP

By Letters to the Editor | From Page: B4

Program sparks lots of questions

By Letters to the Editor | From Page: B4

 
Groom’s parents overwhelmed

By Creators Syndicate | From Page: B5

.

Sports

Aggies get ready for Hawaii by rolling over St. Mary’s

By Bruce Gallaudet | From Page: B1 | Gallery

 
UC Davis represents well at Final Four in Indiana

By Bruce Gallaudet | From Page: B1 | Gallery

 
Descalso looks back at Aggie days, ahead to new Rockies gig

By Bruce Gallaudet | From Page: B1 | Gallery

Blue Devils drop softball game at CBS

By Enterprise staff | From Page: B1

 
JV/frosh roundup: DHS younger girls soccer squad stomps Grant

By Enterprise staff | From Page: B2 | Gallery

UCD roundup: Nunez powers Aggies to softball win

By Enterprise staff | From Page: B3 | Gallery

 
Gibson’s heroics ensure a DHS split at Boras Classic

By Enterprise staff | From Page: B10

.

Features

Spring is a busy time for honey and hives

By Dan Kennedy | From Page: A8 | Gallery

 
.

Arts

Bluesman and guitarist Buddy Guy comes to Davis

By Jeff Hudson | From Page: A9 | Gallery

 
Fiery bluesman brings guitar pyrotechnics to The Palms

By Special to The Enterprise | From Page: A9 | Gallery

 
 
.

Business

.

Obituaries

.

Comics